Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 808.5 JPY 2.31% Market Closed
Market Cap: 642.5B JPY
Have any thoughts about
Rohto Pharmaceutical Co Ltd?
Write Note

Rohto Pharmaceutical Co Ltd
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Rohto Pharmaceutical Co Ltd
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Rohto Pharmaceutical Co Ltd
TSE:4527
Total Current Assets
ÂĄ204.9B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
10%
Shiseido Co Ltd
TSE:4911
Total Current Assets
ÂĄ482.2B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
3%
Kao Corp
TSE:4452
Total Current Assets
ÂĄ826.2B
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
4%
Kose Corp
TSE:4922
Total Current Assets
ÂĄ240.4B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
8%
F
Fancl Corp
TSE:4921
Total Current Assets
ÂĄ59.7B
CAGR 3-Years
5%
CAGR 5-Years
1%
CAGR 10-Years
2%
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Total Current Assets
ÂĄ132.3B
CAGR 3-Years
-8%
CAGR 5-Years
-2%
CAGR 10-Years
3%
No Stocks Found

Rohto Pharmaceutical Co Ltd
Glance View

Market Cap
640.7B JPY
Industry
Consumer products

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. The company is headquartered in Osaka, Osaka-Fu and currently employs 6,596 full-time employees. The firm primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The firm operates its business in domestic market and overseas markets, including Europe, Asia and America.

Intrinsic Value
3 343.8 JPY
Undervaluation 16%
Intrinsic Value
Price

See Also

What is Rohto Pharmaceutical Co Ltd's Total Current Assets?
Total Current Assets
204.9B JPY

Based on the financial report for Sep 30, 2024, Rohto Pharmaceutical Co Ltd's Total Current Assets amounts to 204.9B JPY.

What is Rohto Pharmaceutical Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
10%

Over the last year, the Total Current Assets growth was -1%. The average annual Total Current Assets growth rates for Rohto Pharmaceutical Co Ltd have been 10% over the past three years , 12% over the past five years , and 10% over the past ten years .

Back to Top